Venkatram
7.5K posts

Venkatram
@srir54
Product Leader¦ Deep India - Africa connect¦ SaaS +Avid SME and nano cap investor. Information freak and passionate about India



#PowerEPC #Transmission #HVDC #GRIDCONNECTIVITY #TRANSFORMERS Transmission EPC has order longevity, long execution cycles, and annuity like cash flows. Terminal phase is impossible with structural peak load rising gradually Either be TBCB transmission or say substation upgrades or BESS connected infra,... it's in the NON TERMINAL recurring phase Folks!! Don't simply get carried away by some useless narratives They are in the mid cycle. Clear order visibility for 132/220/400 and 765kv for the next 2-3 years. PGCIL or Discoms are agreeing for the hike in the prices and it's simply a joke for people to compare this with a pure solar epc players EHV will have durable tailwinds here 120 Gw peak demand estimated by 2030 is no joke right!! We are talking about 8 to 9 lacs crores here. Stop kidding 50+ ISTS projects and 15+ green corridors. Come on Folks, don't get carried away Good order visibility for lower ratings to mid(400kv) to higher ratings 765kv PGCIL and Discomms are agreeing for the price hikes and so pricing power is intact and so the margins Don't forget that re rating is driven by the scarcity premium and let's count how many serious transformers OEMS that deliver EHV/HVDC grade.. 12, 15?? Let's go back to the basic. Terminal valuarion require DEMAND STAGNATION + CAPEX SATURATION. Read somewhere that Quality Power is working on 9x capex and so major players like Shilchar, Atlanta, Danish,... Tell the story tellers that a xyxle becomes cyclical only when TAM is almost saturated and pricing power is substantially lost + capex revival is next to impossible and last but not the least... disruptions destroys underlying demand Now u tell me.. Does power EPC and transmission profit pool have any of fhe above?? Solar EpC is a different story altogether. Pure EPC players will hear the music. But they are transitioning towards RTC + hybrid, solar + BESS, C&I.... Will discuss this some other day To re emphasize the demand to get revised further up anytime soon to cater to AI/DC, semicon push, EV loads, grid modernization, bess integration,.... 765kv + hvdc backlogs are surmounting and people should stop joking by passing some pathetic opinions Temporary slowdown in bidding isn't structural death 🤣🤣 Lastly, Valuation follows fundas and nowhere they are near the terminal phase near peaking out



#accretionpharma #accpl is shaping up as an export-led SME CDMO with owned manufacturing, multi-country approvals and improving scale. The key monitor now is execution: product registrations converting into direct exports, better mix, margin recovery and tighter working capital.

#SPML interesting story to watch. Investment note for the interested.

Beezaasan : Scuttlebutt analysis : Quietly building defence capabilities As per one of its peer, Beezaasan is also in the race to get defence licence for RDX, HMX, TNT, Propellent etc. They seem to have already applied for all these licences. The peer also mentioned that it takes 18-24 months from the grant of licence to start production. Last year as per IPO discussions by the management of Beezaasan, their sister company Asawara Earthtech Ltd. had all the defence licenses for production of RDX, HMX, TNT and other products. Recently, Beezaasan acquired 35% stake in this company from promoters. Considering, this company already had defence licences more than a year ago, we expect this company to start the production of defence explosives at the end of FY27 (18-24 months from the grant of licence). Beezaasan's own defence explosive licences might take another two years. Most of the money raised via Beezaasan's IPO would have already been deployed as per the schedule of capex as per DRHP. This expanded capacity should also come on-line during FY27. What all this mean for earnings expectations? 1. Considering new expansion is going to be complete in FY27, FY26 could remain largely muted vs FY25. 2. FY27 : Would see completion of expansion at Beezaasan, may be start of production of defence explosives at 35% owned Asawara Tech. As per Asawara company's valuation report (at the time of preferential issue), Asawara could have a PAT of 58cr in FY27 and 120cr in FY28. Beezaasan's share i.e. 35% of this would be Rs. 20cr and 42cr, respectively. Conservatively, Beezaasan can have a PAT of Rs. 16-25cr, conservatively, assuming delay in start of production at Asawara and may be Beezaasan's expanded capacity as well. If executed well, Beezaasan consolidated PAT could be Rs. 30-40cr in FY27, itself. Better to remain conservative. 3. FY28 : Could see a substantial jump in earnings due to full year of operations at Beezaasan and Asawara new capacity. The PAT could grow to Rs. 40-60cr in FY28 for Beezaasan. 4. FY29 : Could be a big year as the expanded capacity gets scaled up and Beezaasan own defence capacities comes into operation. Conservatively, Beezaasan could have Rs. 100cr PAT. All depends upon execution. FY30 can surprise considering all the defence explosive capacities at Beezaasan and Aswara could be fully operational. Current market cap is Rs. 300cr. Defence explosives is a highly regulated industry and trades at higher valuation multiples. Only for long-term investors with patience. Do your own due-diligence.










Look out for SME companies migrating to the mainboard within the next 6-8 months. There is potential for massive value unlocking..





#accretionpharma #accpl is shaping up as an export-led SME CDMO with owned manufacturing, multi-country approvals and improving scale. The key monitor now is execution: product registrations converting into direct exports, better mix, margin recovery and tighter working capital.

SME BULK DEALS on 17/04/2026 🇳 • ACCORD • Accord Synergy Limited 🟩 • AFZAL AIYUB PATEL • BUY • 20,000 SHARES • ₹38.15 🟥 • AGAM RAHUL SHAH • SELL • 24,000 SHARES • ₹38.15 🟩 • PRAGNYESHBHAI BHARATBHAI PATEL • BUY • 20,000 SHARES • ₹38.15 🟥 • RAHUL SHAH • SELL • 20,000 SHARES • ₹38.15 🟩 • SARFARAZ YAKUB PATEL • BUY • 20,000 SHARES • ₹38.15 🇳 • KRMAYURVED • KRM Ayurveda Limited 🟩 • AFFLUENCE GEMS PRIVATELIMITED • BUY • 2,00,000 SHARES • ₹236.00 🟥 • MANSI SHARE AND STOCK BROKING PRIVATE LIMITED • SELL • 2,02,000 SHARES • ₹235.97 🇳 • KANDARP • Kandarp Dg Smart Bpo Ltd 🟩 • ALTIZEN VENTURES LLP • BUY • 1,01,000 SHARES • ₹141.21 🇧 • 543540 • PGCRL • Pearl Green Clubs and Resorts Ltd 🟩 • GULRAJ LAKSHMANDAS CHANDARAM RAHEJA • BUY • 16,200 SHARES • ₹129.68 🇧 • 543285 • RCAN • Rajeshwari Cans Ltd 🟩 • PHOOLWATI JAIN • BUY • 69,600 SHARES • ₹17.07 🇧 • 544746 • SCDL • Safety Controls & Devices Ltd 🟩 • DEALMONEY COMMODITIES PRIVATE LIMITED • BUY • 115,200 SHARES • ₹81.22 🇳 • SAIFL • Sameera Agro And Infra L 🟥 • SATYA MURTHY SIVALENKA • SELL • 2,60,000 SHARES • ₹10.98 🇳 • SPEB • Speb Adhesives Limited 🟥 • COMPACT STRUCTURE FUND • SELL • 1,78,000 SHARES • ₹55.70 🟩 • POOJA SHALIN JHAVERI • BUY • 1,78,000 SHARES • ₹55.70 🇧 • 544738 • SPML • Speciality Medicines Ltd 🟩 • BHAVNA HITESH PATEL • BUY • 45,000 SHARES • ₹246.45 🟩 • YASH HITESH PATEL • BUY • 50,000 SHARES • ₹238.49 🟩 • YASHVI HITESH PATEL • BUY • 45,000 SHARES • ₹215.96









